Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-02-25 @ 5:49 PM
Study NCT ID:
NCT00520260
Status:
COMPLETED
Last Update Posted:
2009-02-19
First Post:
2007-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
Sponsor:
Florida Eye Microsurgical Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-21
First Submit QC Date:
None
Study First Post Date:
2007-08-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-02-17
Last Update Post Date:
2009-02-19
Last Update Post Date Type:
ESTIMATED